Finance

Lists
Why is OPK down 2,34%?
Dive Deeper
OPK:NASDAQ
OPKO Health Inc
1,67 $
-2,34%
(-0,040) 1D
1,67 $
0,00% (0,00)
After hours
Closed: 12 қар., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
1,71 $
High
1,74 $
Low
1,66 $
Mkt. cap
1,24 млрд
Avg. vol.
5,00 млн
Volume
2,55 млн
52-wk high
1,86 $
52-wk low
0,98 $
EPS
-0,20 $
Beta
1,52
Shares outstanding
742,51 млн
No. of employees
2 мың
Open
1,71 $
High
1,74 $
Low
1,66 $
Mkt. cap
1,24 млрд
Avg. vol.
5,00 млн
Volume
2,55 млн
52-wk high
1,86 $
52-wk low
0,98 $
EPS
-0,20 $
Beta
1,52
Shares outstanding
742,51 млн
No. of employees
2 мың
News stories
From web sources and news partners
About OPKO Health Inc
CEO-
Employees2,28 мың
Founded1991
HeadquartersМайами, Флорида, Америка Құрама Штаттары
SectorHealth Care
IndustryHealth care provider
Websiteopko.com
Analyst ratings
Based on 4 analysts giving stock ratings to OPK in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current 1,67 $
4,00 $ (+139,52%)
Average
3,08 $ (+84,43%)
Lowest
2,25 $ (+34,73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
J.P. Morgan
Hold
Maintained
-
-
11/09/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
4,00 $
+139,5%
11/05/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
3,00 $
+79,6%
11/05/2026
Michael Petusky
Barrington
Buy
Upgraded
2,25 $
+34,7%
10/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
3,00 $
+79,6%
02/27/2026
Last report
2026 ж. 04 қар.
Fiscal period
Q3 2026
-0,05 $ / -0,06 $
+21,05%beat
Revenue / Est. (USD)
65,41 млн / 136,62 млн
-52,12%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
148,45 млн
124,20 млн
163,50 млн
65,41 млн
Cost of goods sold
117,20 млн
107,64 млн
-
25,15 млн
Cost of revenue
117,20 млн
107,64 млн
-
25,15 млн
Research and development expenses
-
-
-
30,38 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,22 млн
48,61 млн
-
24,84 млн
Operating expense
74,27 млн
67,57 млн
-
71,67 млн
Total operating expenses
191,47 млн
175,21 млн
-
96,82 млн
Operating income
-43,02 млн
-51,02 млн
-
-31,41 млн
Other non operating income
-354,00 м.
139,00 м.
-
4,21 млн
EBT including unusual items
-46,92 млн
-60,96 млн
-
-42,87 млн
EBT excluding unusual items
-51,38 млн
-57,31 млн
-
-42,87 млн
Income tax expense
-15,66 млн
-6,11 млн
-
-7,31 млн
Effective tax rate
33,38%
10,02%
-
17,05%
Other operating expenses
-
-
-
-
Net income
-31,26 млн
-54,85 млн
-
-53,53 млн
Net profit margin
-21,06%
-44,16%
-
-81,84%
Earnings per share
-0,04
-
-0,03
-0,05
Interest and investment income
3,82 млн
3,01 млн
-
2,88 млн
Interest expense
-11,31 млн
-10,94 млн
-
-13,45 млн
Net interest expenses
-7,49 млн
-7,93 млн
-
-10,57 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,64 млн
-28,82 млн
-
-8,68 млн
Gain or loss from assets sale
601,00 м.
-34,00 мың
-
47,00 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары